Psychiatric disorders in neurology by Taj, Rizwan & Manzoor, Mamoona
Pakistan Journal of
Neurological Sciences (PJNS)
Volume 9 | Issue 3 Article 14
7-2014
Psychiatric disorders in neurology
Rizwan Taj
Pakistan Institute of Medical Sciences,Islamabad,Pakistan
Mamoona Manzoor
Pakistan Institute of Medical Sciences,Islamabad,Pakistan
Follow this and additional works at: http://ecommons.aku.edu/pjns
Part of the Neurology Commons
Recommended Citation
Taj, Rizwan and Manzoor, Mamoona (2014) "Psychiatric disorders in neurology," Pakistan Journal of Neurological Sciences (PJNS): Vol.
9: Iss. 3, Article 14.
Available at: http://ecommons.aku.edu/pjns/vol9/iss3/14
STROKE
Stroke is the third leading cause of death in developed 
countries. Psychiatric syndromes associated with stroke 
lead to significant psychological distress, functional impair-
ments, poor rehabilitation outcomes, and excess mortality. 
Most common psychiatric disturbances seen after stroke 
include cognitive impairment and dementia, depression, 
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ABSTRACT
Psychiatric disorders (PDs) are very frequent in neurological illnesses. Depression, anxiety and cognitive impairment are 
frequently seen in many neurological disorders such as stroke, Parkinson disease (PD), epilepsy and multiple sclerosis (MS). In 
addition, hallucinations, delusions, obsessive-compulsive disorder, sleep disorders, Impulse control disorders (ICDs), somatiza-
tion, bipolar disorder, behavior problems and psychological problem are also seen. Depression in stroke and epilepsy has 
bidirectional relationship. Lesion location affects both frequency and severity of depression in stroke patients. Hallucinations 
and delusions are frequent in patients with Parkinson disease and epilepsy. In Parkinson’s, these are associated with disease 
itself and are also secondary to treatment while in epilepsy, psychosis can be peri-ictal and interictal or post-ictal. Suicidal 
ideation are prominent in MS and epilepsy patients. Suicide is considered to be an important contributor to the increased 
mortality of persons with epilepsy. Features of depression and dementia may overlap with symptoms of neurological illnesses 
especially in multiple sclerosis, parkinsonism and stroke thus confounding the identification of these disorders. The presence 
of co morbid psychiatric illnesses in neurological patients should be of particular concern to physicians as they increase severity 
of neurological problem, lead to more functional impairment and increase mortality. Clinicians must aim to identify those 
patients with co morbid illness most likely to benefit from interventions and psychiatric or psychotherapeutic treatment should 
be provided to them.Psychiatric disorders (PDs) are very frequent in neurological illnesses. Depression, anxiety and cognitive 
impairment are frequently seen in many neurological disorders such as stroke, Parkinson disease (PD), epilepsy and multiple 
sclerosis (MS). In addition, hallucinations, delusions, obsessive-compulsive disorder, sleep disorders, Impulse control disorders 
(ICDs), somatization, bipolar disorder, behavior problems and psychological problem are also seen. Depression in stroke and 
epilepsy has bidirectional relationship. Lesion location affects both frequency and severity of depression in stroke patients. 
Hallucinations and delusions are frequent in patients with Parkinson disease and epilepsy. In Parkinson’s, these are associated 
with disease itself and are also secondary to treatment while in epilepsy, psychosis can be peri-ictal and interictal or post ictal. 
Suicidal ideation are prominent in MS and epilepsy patients. Suicide is considered to be an important contributor to the 
increased mortality of persons with epilepsy. Features of depression and dementia may overlap with symptoms of neurological 
illnesses especially in multiple sclerosis, parkinsonism and stroke thus confounding the identification of these disorders. The 
presence of co morbid psychiatric illnesses in neurological patients should be of particular concern to physicians as they 
increase severity of neurological problem, lead to more functional impairment and increase mortality. Clinicians must aim to 
identify those patients with co morbid illness most likely to benefit from interventions and psychiatric or psychotherapeutic 
treatment should be provided to them.Psychiatric disorders (PDs) are very frequent in neurological illnesses. Anxiety and 
depression are most common, but hallucinations, delusions, obsessive-compulsive disorder and delirium or confusional state 
are also frequent comorbidity in many neurological conditions such as stroke, epilepsy, multiple sclerosis (MS), Parkinson 
disease (PD). With a growing body of research showing strong links between neurological and psychiatric illnesses, there is 
need to understand the co morbidity of psychiatric illnesses in neurological disorders.
mania, anxiety disorders, and pathological laughing and 
crying - now referred to as involuntary emotion expression 
disorder or IEDD.Vascular cognitive impairment and post 
stroke dementia, a condition that can be found in 20% to 
30% of stroke patients.(1,2) Cognitive evolution 2 years after 
stroke is rather heterogeneous, but a substantial number of 
patients remain stable or even improve 3 with time. The 
determinants of progression of cognitive impairment are still 
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poorly known. Age, previous cognitive decline, polypharma-
cy, and hypotension during admission are risk factors for 
progression.(4) The predictor of cognitive change which has 
a protective role, is years of education.(5)Post stroke demen-
tia increases the risk for recurrent stroke and mortality.(6-8)  
Appropriate management of vascular risk factors is an 
important preventive treatment strategy to decrease the risk 
of stroke recurrence and cognitive impairment. Effective 
secondary prevention could help to prevent or delay the 
onset of severe global cognitive impairment.Psychiatric 
disorders, mostly depression, are fairly common in stroke 
survivors. Depression and anxiety are significantly correlated 
to the patient's psychopathological profile. Some form of 
depression is considered to occur in at least one-quarter of 
patients in the first year after acute stroke(9), with the period 
of greatest risk being the first few months after onset (9,10,11). 
Lesion location is most important in determining frequency 
and severity of depression. Researches show that patients 
with left hemisphere frontal lobe infarctions who are within 
2 years of the stroke, are at high risk for developing post 
stroke depressive disorders (12). Other variables including 
functional physical impairment, intellectual impairment, 
quality of social support, and age contribute to or modify 
depression (13).The presence of depression in stroke 
patients should be of particular concern to physicians as 
depression reduces the desire and capacity to participate in 
rehabilitation (14), and affected people are less inclined to 
socialize (socialization is thought to be protective of mood 
disorders. It may put people at a greater risk of adverse 
health behaviors, such as poor adherence to medications. 
So physicians should be careful in identifying depression in 
patients for stroke.Remarkable features of emotional 
behavior, such as disinhibition, denial, indifference, overt 
sadness and aggressiveness, are not rare during the acute 
phase of stroke. Some of these early behaviors, such as 
denial, may relate to the late development of depression, 
anxiety and other disorders (15).Anxiety disorders, especially 
agoraphobia, are relatively common (20% if diagnosed in 
the presence of depressive disorder), but are not related to 
lesion location or volume (16).Emotional blunting or apathy 
has been reported to constitute a frequent sequel of stroke 
lesions. Apathy is found in about 23 % patients with acute 
stroke lesions and may coexist with important emotional 
and cognitive post stroke disturbances (17). The hypo activity 
in the frontal lobe and anterior temporal regions may 
contribute to symptoms of apathy after stroke. Unilateral, 
usually sub cortical, strokes can also produce pathologic 
laughter (18).Parkinsonism Parkinson's disease PD is the 
second most common neurodegenerative disease and is 
characterized by the cardinal signs of bradykinesia, rigidity, 
tremor at rest, and abnormalities of balance, posture, and 
gait (19). The psychiatric symptoms and syndromes associat-
ed with Parkinson's disease are either those unrelated to 
Parkinsonism, reactive mental disturbances or psychiatric 
symptoms caused by medication.Mild cognitive impairment 
(MCI) is common in patients with PD without dementia, 
affecting a range of cognitive domains, including memory, 
visual-spatial, and attention/executive abilities (20).Cognitive 
impairment in subjects with early, drug-naïve Parkinson 
disease (PD) is two times greater than the general popula-
tion (21).  Although, Patients with PD and MCI had a higher 
risk of developing dementia than cognitively intact PD 
patients, suggesting that MCI in PD is an early manifestation 
of dementia (22). But prevalence of patients of PD developing 
dementia even in absence of initial MCI is much higher than 
general population, (about 75% in a study after 8 years). 
Patients with akinetic-dominant PD and hallucinations prior 
to the baseline evaluation are at higher risk of developing 
dementia than those with tremor-dominant parkinsonism 
and without hallucinations (23).Depression is common in 
PD, with a prevalence of 25% to 50% over the course of the 
illness and there may be overlap in the pathophysiology of 
the two conditions.  As in the case of epilepsy and stroke, 
depression and PD appear to have a bidirectional relation-
ship. That is, not only are patients with PD at greater risk to 
developing depresion, but patients with a depressive disor-
der have been found to be at greater risk of developing PD. 
(24)Anxiety disorders, particularly generalized anxiety, panic, 
and social phobia, occur in up to 40% of patients with 
Parkinson's disease (PD) and often coexists with depres-
sion.  Current evidence suggests that anxiety may not be a 
psychological reaction to the illness but rather may be 
linked to specific neurobiological processes accompanying 
PD. (25)Impulse control disorders (ICDs), including compul-
sive gambling, buying, sexual behavior, and eating, can 
occur as a complication of Parkinson's disease (PD). In 
addition, other impulsive or compulsive disorders have been 
reported to occur, including dopamine dysregulation 
syndrome (DDS) and punding. Male gender, younger age at 
PD onset, a pre-PD history of ICD symptoms, personal or 
family history of substance abuse or bipolar disorder, and a 
personality style characterized by impulsiveness are some of 
the risk factors for an ICD in patients of PD (26). Various 
studies have sought to identify obsessive-compulsive symp-
toms (OCS) in PD. Tomer et al.(27) described higher scores of 
OCS in PD; Alegret et al. found that patients with severe PD 
presented more obsessive traits than controls, and severity 
of OCS was related to the severity and duration of PD. 
Tomer et al. also observed an association between the 
severity of motor symptoms on the left side of the brain and 
OCS related to cleanliness and repetition, whereas they 
found OCS related to order/routine to be correlated with the 
right side (27). However Maia AF found that OCD, OCS, and 
related disorders were not higher in PD (29). Their findings 
revealed an association of some OCS with left side motor 
symptom predominance in PD patients, particularly for 
symmetry and ordering/arranging. allucinations and 
delusions are frequent in patients with Parkinson disease. 
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Hallucinations, usually of visual modality, occur in about 
30% of patients with PD, and delusions have been found in 
10%.(30) In a recent study,(31) visual hallucinations were 
reported in 26% of patients with PD. Hallucinations and 
delusions in patients with PD were reported before the 
introduction of dopaminergic therapy but are usually consid-
ered to represent behavioral complications of drug 
treatment,(30) Some evidence (30,31,32)  suggests that demen-
tia, advanced age, administration of high daily doses of 
levodopa, premorbid psychiatric illness, and multidrug 
therapy are risk factors for psychotic symptoms in 
PD.Knowledge of these phenomena and their association 
with other clinical characteristics of PD is important for the 
diagnosis and treatment of patients and can provide 
information regarding the future needs for health care. 
Sleep problems are much more common in PD patients  
and correlate with increased severity of disease , levodopa 
dose, rigidity score, and bradykinesia score.(33) Inappropriate 
crying and laughing (also termed pseudobulbar affect (PBA) 
are present in most movement disorders, but especially 
prevalent in parkinsonism. PBA patients have more chronic 
depressive symptoms and tiredness (34).Nonmotor features 
of PD such as dementia, depression, and psychosis may 
result in significant disability.(35) Furthermore, many PD 
symptoms overlap with features of depression and demen-
tia including symptoms of withdrawal, lack of motivation, 
flattened affect, decreased physical activity, or bradyphre-
nia, thus confounding the identification of these behavioral 
and cognitive disorders
EPILEPSY
Psychiatric illnesses are very commonly associated with 
epilepsy.Mood disorders are the most common culprit 
(24–74%), particularly depression (30%), followed by anxie-
ty disorders (10–25%), psychoses (2–7%) and personality 
disorders (1–2%). This comorbidity appears to be related to 
endogenous and exogenous (including iatrogenic) factors 
and to the severity and chronicity of epilepsy. Conditions 
such as schizophrenia-like psychosis of epilepsy and interic-
tal dysphoric disorder are represented only in epilepsy (36).
Depression is more frequent in patients with epilepsy 
compared to the general population. Population studies 
revealed a frequency of depression varying from 9% to 22% 
in patients with epilepsy, while hospital series usually report 
higher rates of depression (27% to 58%) for patients with 
epilepsy (37). For some authors, this prevalence is higher 
(60-80%) in patients with refractory TLE, although this is still 
controversial (36). Patients with longer duration of epilepsy 
are at higher risk of having depression.Relationship between 
epilepsy and depression is bidirectional (38). Thus, patients 
with epilepsy are more likely to develop depressive disor-
ders, and patients with a history of depression or suicide 
attempt have a higher risk of developing epilepsy. Depres-
sion has greater negative impact on quality of life than 
seizure frequency or the number of prescribed antiepileptic 
drugs (39). In addition, depression in epilepsy is associated 
with reduced seizure control (40).Although mood disorders 
represent a frequent psychiatric comorbidity among 
patients with epilepsy, data regarding bipolar disorders are 
still limited. Emerging evidence suggests that mood instabil-
ity, mixed irritability, or even mania is not uncommon in 
patients with epilepsy (41). Patients with epilepsy may be 
subject to an increased risk of premature death from the 
underlying cause, or from the epilepsy in itself. Mortality in 
patients with newly-diagnosed epilepsy is found to be high, 
mainly due to the underlying cause (42). Suicide is consid-
ered to be an important contributor to the increased mortal-
ity of persons with epilepsy. The collective data of different 
studies yield an average rate of approximately 12% of 
deaths due to suicide among people with epilepsy, 
compared with 1.1–1.2% in the general population. Poten-
tial risk factors for suicide are primary mood disorders, 
family issues, physical health, personality, life stress, 
previous suicidal behavior, and access to firearms. Assess-
ing severity of risk helps to determine the appropriate level 
of intervention. Epileptic psychoses are categorised as 
peri-ictal and interictal according to their relationship with 
the occurrence of seizures. However, while post ictal 
psychosis constitutes a rather homogenous clinical entity, 
interictal psychosis is apparently quite heterogeneous. The 
treatment of peri-ictal or acute mental disorders is based on 
epileptic seizure control, while the treatment of interictal or 
chronic disorders has more in common with managing 
disorders which are purely psychiatric in origin. In addition to 
improving the patient's quality of life and reducing disability, 
achieving strict control over seizures may also prevent the 
development of interictal psychosis. Longer evolution of 
seizures and the presence of bilateral hippocampal sclerosis 
may increase propensity to develop psychoses in patients 
with refractory partial epilepsy (44).Memory problems are one 
of the chief complaints of patients with temporal lobe 
epilepsy (TLE). Epileptic seizures might trigger neurodegen-
erative changes leading eventually to memory impairments 
(45). Interictal epileptiform discharges are associated with 
neuropsychological disorders like cognitive impairment and 
behavioral problems even in absence of clinical epilepsy (46). 
Obsessive-compulsive symptoms OCS are more likely to 
develop in patients with epilepsy than in healthy people. The 
development of OCS appears to elicit psychosocial 
problems directly or indirectly by provoking depression or 
uncontrolled seizures (47).Children with seizures are at risk 
for behavior problems. Studies show that children with 
seizures were 4.7 times more likely to have a behavior 
problem as compared with controls (48). The specific behav-
iors and traits that were most problematic for children with 
seizures are being hyperactive (cannot concentrate, easily 
confused, impulsive, obsessive, and restless) and depend-
| 5 0 | V O L .  9  ( 3 )  J U LY   -   S E P T E M B E R   2 0 1 4P A K I S T A N  J O U R N A L  O F  N E U R O L O G I C A L  S C I E N C E S
ent (clings to adults, cries a lot, demands a lot of attention, 
too dependent on others). Multiple Sclerosis (MS) Multiple 
Sclerosis is a chronic autoimmune demeylinating disease of 
the central nervous system. In the variable course and 
progression of symptoms in this disease, patients may 
experience episodic, chronic, or progressive symptoms 
including fatigue, pain, spasticity, loss of use of their arms 
and legs, loss of vision, impaired bowel and bladder 
function, and sexual problems.Symptoms of depression, 
anxiety and sleep impairment are common in MS patients. 
Less studied symptoms such as somatization, obsession, 
compulsion, interpersonal sensitivity, anger-hostility, phobic 
anxiety, paranoid ideation, psychoticism, low self-esteem 
and distorted eating attitudes are also more frequent 
compared to the healthy controls. Symptoms increase as 
degree of disability rises and ambulatory capacity declines 
(49).Neuropsychiatric symptoms of MS can be grouped into 
two categories: cognitive and mood. Amongst the latter, the 
most widely noted are depression, bipolar disease and 
pseudobulbar affect. Other psychiatric symptoms include 
irritability, apathy, disinhibition and euphoria.Individuals with 
MS have a prevalence of depression, that is higher 
compared to the general population. Prevalence of signifi-
cant depressive symptoms in MS has been reported as 
41.8% with 25% meeting criteria for major depressive disor-
der (50). Suicidal ideation is prominent in MS patients with 
the prevalence of 30 %. Bipolar disease is also 2-3 times 
more common in this population (51).Cognitive deficits occur 
in at least half of all adult individuals with MS. Recent 
studies have highlighted deficits in attention, executive 
function and working memory in the pediatric age group, 
even in the absence of significant physical impairment (52). 
Such cognitive loss may be a consequence of disease 
affecting the maturation process of the white matter 
pathways in the frontal lobe Prevalence of poor self-reported 
sleep quality as well as sleep disorders, such as insomnia 
and restless legs syndrome, is higher in patients with MS 
compared with the general population. Poor sleep quality 
has been associated with greater disease severity, pain, and 
poorer mental and physical quality of life in patients with MS 
(53). Insomnia symptoms are commonly associated with 
depression and anxiety, and thus may cause or exacerbate 
sleep disturbance in patients with MS (54).Demoralization 
is particularly complex in the context of MS because of the 
intermittent nature of the condition, which can make it 
particularly difficult to cope with. Over time many MS 
patients find it increasingly difficult to adapt psychologically 
to new episodes and that this can adversely impact their 
relationships and psychosocial functioning.
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